Volume 4 Supplement 1

7th German Conference on Chemoinformatics: 25 CIC-Workshop

Open Access

Postprocessing of molecular docking poses using binding free energy calculations

Journal of Cheminformatics20124(Suppl 1):P42

DOI: 10.1186/1758-2946-4-S1-P42

Published: 1 May 2012

The main key to success in structure-based drug discovery is the accurate prediction of binding affinities of hit compounds. Molecular docking and scoring functions are often used for this purpose. However, it is often found that the top-ranked docking poses do not represent the right binding mode, and frequently there is no correlation between docking score and biological data. Therefore, “post-processing” of docking poses has recently got attraction. In previous work [1], we have successfully computed binding free energies (MM/PBSA) of 222 Wee1 kinase inhibitors and used the derived validated models for virtual screening. In the current work, we extended our studies to a data set of PIM1 kinase inhibitors. Cross-docking studies showed that the correct binding mode of the inhibitors can be determined after applying a post-processing procedure. The top-ranked docking poses gave wrong binding mode (high RMSD values ~4.0 Å), whereas the top-ranked poses selected after postprocessing yielded RMSD values around 0.5 Å. Subsequently, the docking poses giving the lowest binding free energy were selected and these values were used to establish a correlation with experimental data. A significant correlation between ΔGcal. and ΔGexp (r 2 = 0.58) was obtained. To summarize, the protocol described in the current work can be used for postprocessing of protein-ligand docking poses and for predicting biological activities of novel hits. Therefore, the protocol can be applied for structure-based optimization of hit molecules.

Authors’ Affiliations

Department of Pharmaceutical Chemistry, Martin-Luther University Halle-Wittenberg


  1. Wichapong K, Lawson M, Pianwanit S, Kokpol S, Sippl W: Postprocessing of Protein-Ligand Docking Poses Using Linear Response MM-PB/SA: Application to Wee1 Kinase Inhibitors. J Chem Inf Model. 2010, 50: 1574-1588. 10.1021/ci1002153.View ArticleGoogle Scholar


© Wichapong and Sippl; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.